About us

iMed.pub is a publisher of scholarly open access journals and books. 

All journals uphold a peer-reviewed, rapid, and rigorous manuscript handling and editorial process. iMed.pub journals are the perfect place for you to publish your work under anOpen Access license, in a fast and straightforward manner, and to reach a wide readership. iMed.pub delivers over two million webpage views and over a half million full-text downloads per month.


Vision

As a service to doctors and biomedical scientists, iMed.pub is driven by clinicians and researchers for themselves, while serving the interests of the general public. iMed.pub disseminates research in a tiered system, beginning with our specialty books and journals and then working upwards. The grand vision of iMed.pub is a world where all medical researchers and health professionals have an equal opportunity to seek, share and create knowledge. 

Mission

iMed.pub aims to address the needs of authors and foster a rapid, convenient, unbiased, and comprehensive publishing environment, which not only guarantees the highest quality constructive peer-review process, but also provides an evaluation system that involves the entire research community. To fulfill this mission, iMed.pub applies the most advanced Internet technologies to bring scholarly publishing into a new generation.


Objectives
To provide a new publishing system that

  • drives an increase in the quality of science world-wide;
  • disseminates science freely;
  • distills academic excellence;
  • delivers the most outstanding and relevant science to the public;
  • provides a new academic model for review.

To provide an evaluation and recognition system for authors that is

  • rapid and efficient;
  • fair and constructive;
  • rigorous and prestigious.
  • bilingual English-Spanish.

To provide a new business model that

  • serves publishing needs of researchers;
  • obtains sponsors to support open access research publishing,
  • aid pharmaceutical companies in reinforcing their brand messages, and to produce customized content to integrate with global and local communication plans.


Affiliation
iMedPub is an active member of the Publishers Licensing Society, the Association of Learned and Professional Society Publishers and Crossref.  We also support the ORCID project (Open Researcher & Contributor ID) and CHORUS. We are a member of Equip

 

Relationships
We sustain close collaboration with several important academic institutions and medical organizations, including Asociación de Estudiantes de Medicina de Panamá, CEDEPAP, The Arab Alliance for the Prudent Use of Antimicrobials and European Society for Translational Medicine. We also work in close collaboration with other publishing houses as EDIKAMED.

We are a signatory of the Budapest Open Access Initiative, which states that open access “…will accelerate research, enrich education, share the learning of the rich with the poor and the poor with the rich, make this literature as useful as it can be, and lay the foundation for uniting humanity in a common intellectual conversation and quest for knowledge.”.

We endorse the Transfer Code of Practice (NISO). We also endorse the Panton Principles, which state that "for science to effectively function, and for society to reap the full benefits from scientific endeavours, it is crucial that science data be made open".

As members of CLOCKSS (Controlled Lots of Copies Keep Stuff Safe) our content is regularly archived with many of the world's leading research libraries. The CLOCKSS archive ensures that iMed.pub content will always be made available as open access, in any eventuality.

All iMed.pub  content is assigned a Digital Object Identifier (DOI) from CrossRef. This means that our content can be found quickly and easily because links in citations and references will always work. It also enables us to track citations to our articles, to demonstrate their impact.


Join us

Getting permission for using iMedPub's contents

If you need to get permission for using any copyrighted content published by us, please follow this button 

Get Permissions